Literature DB >> 3402606

Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy.

E Ben-Hur1, E Heldman, S W Crane, I Rosenthal.   

Abstract

Photodynamic treatment of solid tumors results in the occlusion of blood vessels in the treated tissue. We hypothesize that this process is triggered by the release of one or more clotting factors from the photodamaged endothelial cells. Experimental evidence is presented that immediately after photodynamic treatment, cultured endothelial cells start releasing clotting factors into the medium in a dose range of minimal cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402606     DOI: 10.1016/0014-5793(88)80294-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.

Authors:  Flávia Cristina Perillo Rosin; Ana Rita Ribeiro Barcessat; Giuliana Gadoni Giovanni Borges; Luciana Gonçalves Valente Ferreira; Luciana Corrêa
Journal:  Lasers Med Sci       Date:  2016-12-21       Impact factor: 3.161

Review 2.  Toward a molecular understanding of the photosensitizer-copper interaction for tumor destruction.

Authors:  Saleh Al-Omari
Journal:  Biophys Rev       Date:  2013-04-04

Review 3.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

4.  The photodynamic response of two rodent tumour models to four zinc (II)-substituted phthalocyanines.

Authors:  J E Cruse-Sawyer; J Griffiths; B Dixon; S B Brown
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro.

Authors:  W J de Vree; A N Fontijne-Dorsman; J F Koster; W Sluiter
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

6.  Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.

Authors:  J Gołab; G Wilczyński; R Zagozdzon; T Stokłosa; A Dabrowska; J Rybczyńska; M Wasik; E Machaj; T Ołda; K Kozar; R Kamiński; A Giermasz; A Czajka; W Lasek; W Feleszko; M Jakóbisiak
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

7.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Authors:  L Lilge; M C Olivo; S W Schatz; J A MaGuire; M S Patterson; B C Wilson
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

8.  Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.

Authors:  E Debefve; B Pegaz; H van den Bergh; G Wagnières; N Lange; J-P Ballini
Journal:  Angiogenesis       Date:  2008-03-07       Impact factor: 9.596

Review 9.  Potential of Cyanine Derived Dyes in Photodynamic Therapy.

Authors:  Natalia Lange; Wojciech Szlasa; Jolanta Saczko; Agnieszka Chwiłkowska
Journal:  Pharmaceutics       Date:  2021-05-31       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.